Edwards Lifesciences executive Daniel Lippis exercised Options covering 619 shares at $72.68 each and sold 619 shares at $87.51 each on September 11, 2026. The transactions left him with 40,034 shares and 3,714 derivative securities, while the exercise represented about 14.3% of his prior derivative-securities holding.

Key Highlights

  • Daniel Lippis held 40,034 Edwards Lifesciences shares after selling 619 shares at $87.51 each.
  • The option exercise left Lippis with 3,714 derivative securities.
  • The 619 derivative securities exercised represented about 14.3% of his prior derivative-securities holding.

Edwards Lifesciences Corp (NYSE: EW) executive Daniel Lippis exercised options covering 619 shares at $72.68 per share on September 11, 2026. He also sold 619 shares at $87.51 per share on the same date.

Option Exercise And Share Sale

The exercise left him with 40,653 shares of Edwards Lifesciences. Transaction code S identified the sale, after which his shareholding stood at 40,034 shares. The exercise and sale each involved 619 shares. The sale price was $87.51 per share, compared with the $72.68 exercise price.

Derivative Securities And Resulting Holdings

The option exercise also covered 619 derivative securities and left Lippis with 3,714 derivative securities. That transaction represented about 14.3% of his prior derivative-securities holding. The 619-share exercise represented about 1.5% of his resulting shareholding of 40,653 shares. The 619-share sale represented about 1.5% of his prior shareholding.